Latest Articles

  • Use and misuse of opioid agonists in opioid addiction
    Use and misuse of opioid agonists in opioid addiction
    Vania Modesto-Lowe, MD, MPH, Katie Swiezbin, BS, Margaret Chaplin, MD and Gabriela Hoefer
    Cleveland Clinic Journal of Medicine May 2017, 84 (5) 377-384; DOI: https://doi.org/10.3949/ccjm.84a.16091

    Methadone and buprenorphine can reduce craving and opioid use but remain misunderstood and underused.

  • Diabetes control during Ramadan fasting
    A. V. Raveendran, MBBS, MD and Abdul Hamid Zargar, MBBS, MD, DM
    Cleveland Clinic Journal of Medicine May 2017, 84 (5) 352-356; DOI: https://doi.org/10.3949/ccjm.84a.16073

    For diabetic patients, fasting during Ramadan can cause wide fluctuations in blood sugar levels.

  • In reply: Serotonin syndrome (November 2016)
    Vishal Vashistha, MD, Sukhdeep Kaur, MD, Robert Z. Wang, MD and Gregory Rutecki
    Cleveland Clinic Journal of Medicine May 2017, 84 (5) 342-343; DOI: https://doi.org/10.3949/ccjm.84c.05002
  • Left ventricular thrombosis can still complicate acute myocardial infarction
    Left ventricular thrombosis can still complicate acute myocardial infarction
    Muhammad Umer Tariq, MD, Ali M. Tariq, MD, Carmela D. Tan, MD, E. Rene Rodriguez, MD and Venu Menon, MD
    Cleveland Clinic Journal of Medicine November 2016, 83 (11) 819-826; DOI: https://doi.org/10.3949/ccjm.83a.14078

    Despite revascularization, the next day the patient had an ejection fraction of 35% and a mass in the left ventricle.

  • Breaking the pain contract: A better controlled-substance agreement for patients on chronic opioid therapy
    Daniel G. Tobin, MD, FACP, Kristine Keough Forte, MS, MA, DBioethics and Summer Johnson McGee, PhD, CPH
    Cleveland Clinic Journal of Medicine November 2016, 83 (11) 827-835; DOI: https://doi.org/10.3949/ccjm.83a.15172

    Common limitations of current pain treatment “contracts,” and strategies to improve them.

  • Bioresorbable stents: The future of interventional cardiology?
    Stephen G. Ellis, MD and Haris Riaz, MD
    Cleveland Clinic Journal of Medicine November 2016, 83 (11 suppl 2) S18-S23; DOI: https://doi.org/10.3949/ccjm.83.s2.03
  • PCSK9 inhibition: A promise fulfilled?
    Khendi White, MD, Chaitra Mohan, MD and Michael Rocco, MD
    Cleveland Clinic Journal of Medicine November 2016, 83 (11 suppl 2) S36-S44; DOI: https://doi.org/10.3949/ccjm.83.s2.05
  • Serotonin syndrome: Preventing, recognizing, and treating it
    Robert Z. Wang, MD, Vishal Vashistha, MD, Sukhdeep Kaur, MBBS and Nathan W. Houchens, MD
    Cleveland Clinic Journal of Medicine November 2016, 83 (11) 810-816; DOI: https://doi.org/10.3949/ccjm.83a.15129

    Serotonin syndrome can be easily overlooked, misdiagnosed, or exacerbated. Early recognition is critical.

  • Evolution of heart failure management: Miles to go
    James B. Young, MD
    Cleveland Clinic Journal of Medicine October 2016, 83 (10) 766-768; DOI: https://doi.org/10.3949/ccjm.83a.16043

    Despite progress, too many patients still suffer, too many die too young, and the costs are still too great.

  • The ABCs of managing systolic heart failure: Past, present, and future
    Ike S. Okwuosa, MD, Oluseyi Princewill, MD, MPH, Chiemeke Nwabueze, MD, Lena Mathews, MD, Steven Hsu, MD, Nisha A. Gilotra, MD, Sabra Lewsey, MD, MPH, Roger S. Blumenthal, MD and Stuart D. Russell, MD
    Cleveland Clinic Journal of Medicine October 2016, 83 (10) 753-765; DOI: https://doi.org/10.3949/ccjm.83a.16006

    Digitalis, diuretics, and bedrest have given way to neurohormonal blockade and physical rehabilitation.

Pages